Stress, Cortisol, and Melasma: What the Research Actually Shows

Melasma is one of the most common pigmentary conditions dermatologists see: symmetrical brown or grayish-brown patches, usually across the cheeks, forehead, upper lip, or bridge of the nose, that tend to darken with sun exposure and can be stubbornly slow to fade. The condition disproportionately affects women, people with more melanin-rich skin, and those who are pregnant or taking hormonal birth control, and its two best-established triggers, ultraviolet and visible light exposure and hormonal shifts, are not in dispute among dermatologists. What is less settled, and increasingly discussed in wellness spaces, is whether chronic psychological stress is also a meaningful driver of melasma, separate from sun and hormones.

The biological argument for a stress connection isn't invented. A 2025 review in the International Journal of Dermatology on melasma pathogenesis describes how chronic stress and depression can raise levels of cortisol and pro-opiomelanocortin, or POMC, a precursor molecule that the body also processes into melanocyte-stimulating hormone and adrenocorticotropic hormone. Both of those downstream peptides have documented melanogenic potential, meaning they can, in principle, prompt melanocytes to produce more pigment. That gives stress a plausible molecular pathway into pigmentation, running through the same hypothalamic-pituitary-adrenal axis that governs the rest of the body's cortisol output.

Separately, researchers have looked at how often people with melasma also struggle with mental health. A 2025 cross-sectional study in Frontiers in Psychiatry, which surveyed 264 melasma patients in China, found depression in roughly a third of participants and anxiety in about one in five, both well above general population rates. But the authors describe this as a bidirectional relationship rather than a simple stress-causes-melasma story: a visible, hard-to-treat facial condition can itself be a significant source of distress, and that distress may or may not be feeding back into the skin. Untangling which direction the arrow points, in any individual case, is not something a cross-sectional survey can do.

This is where it's worth being precise about what dermatology actually considers settled. Sun and visible light exposure, hormonal changes from pregnancy or hormonal medications, and genetic predisposition all have decades of consistent clinical evidence and are the pillars of how melasma is understood and treated. Chronic stress's specific, independent contribution is biologically plausible but far thinner: there is no large controlled trial showing that stress reduction alone, without addressing sun exposure or hormonal factors, meaningfully improves melasma.

That distinction matters because melasma sometimes gets used in wellness marketing as a poster child for "cortisol damage" to the skin, implying that stress management or a supplement could meaningfully fade it. That overstates what the current research supports. The POMC pathway is a real, published mechanism, and the psychiatric comorbidity data is real too, but neither adds up to stress being an established, independent cause of melasma the way sun exposure is.

The practical picture is fairly clear. Daily broad-spectrum sun protection, avoiding known hormonal triggers where medically possible, and dermatologist-guided topical treatment remain the interventions with real evidence behind them for melasma itself. Given how often melasma coexists with depression and anxiety, attending to mental health is worthwhile in its own right, for wellbeing rather than as a pigmentation treatment, and is best done alongside, not instead of, standard dermatologic care.